‘Enough doubt’ over AstraZeneca jab risks in under-30s to advise alternative

There was “enough doubt” over the risks of the AstraZeneca vaccine in under-30s to advise alternative jabs for younger age groups, the deputy chairman of the Joint Committee on Vaccination and Immunisation (JCVI) has said.